Zonisamide NDC 59651-379

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-379Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0379Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59651-379-01	59651037901	100 CAPSULE in 1 BOTTLE (59651-379-01)Marketed from Aug 17, 2020
59651-379-03	59651037903	30 CAPSULE in 1 BOTTLE (59651-379-03)Marketed from Aug 17, 2020
59651-379-05	59651037905	500 CAPSULE in 1 BOTTLE (59651-379-05)Marketed from Aug 17, 2020
59651-379-60	59651037960	60 CAPSULE in 1 BOTTLE (59651-379-60)Marketed from Aug 17, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zonisamide
Generic name (nonproprietary): zonisamide
Active ingredients: Zonisamide — 50 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077645
Marketing start: Aug 17, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)P-Glycoprotein Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 59651-379_b43ac632-68f3-43f6-aa79-41429a54e1efSPL ID b43ac632-68f3-43f6-aa79-41429a54e1efSPL set ID ab0631ca-5339-4570-bc27-f1dd92de1d6fRxCUI 314285, 403966, 403967UNII 459384H98V
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651037901 followed by a unit qualifier and the quantity

Package 59651-0379-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 9, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Zonisamide capsules USP are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)